Skip to main content

Table 1 Characteristics of 3575 subjects of the Doetinchem Cohort in round 2 and 3

From: Genetic variants in lipid metabolism are independently associated with multiple features of the metabolic syndrome

 

Round 2: 1993-1997

Round 3: 1998-2002

Age (yr)

46.5 (9.7)

51.5 (9.7)

Sex (% men)

47.8

47.8

Waist circumference (cm)

90.2 (11.1)

92.9 (11.4)

Increased waist circumference (%)a

31.3

40.3

Glucose levels (mmol/L)b

5.3 (1.3)

5.4 (1.5)

Diabetic medication (%)

0.8

2.3

Hyperglycemia (%)a

28.8

33.6

HDL-cholesterol (mmol/L)

1.38 (0.38)

1.37 (0.39)

Low HDL-cholesterol (%)a

25.4

29.0

Diastolic Blood Pressure (mm Hg)

79.9 (10.6)

81.4 (10.7)

Systolic Blood Pressure (mm Hg)

125.1 (16.4)

129.3 (18.01)

Hypertension (%)a

50.8

58.5

Blood Pressure lowering medication (%)

6.5

11.0

MetS-score (number of features)

1.34 (1.1)

1.61 (1.1)

Metabolic syndrome prevalence (%)

14.9

22.7

  1. Data are presented as means (standard deviation) or %
  2. aAbdominal obesity, hyperglycemia, low HDL, hypertension and MetS are defined according to the criteria of AHA-NHLBI (2005). Abdominal obesity: ♂ ≥ 102 cm; ♀ ≥ 88 cm; Low HDL: ♂ < 1.0; ♀ < 1.3 mmol/L; hypertension: ≥ 130/85 mm Hg or hypertensive medicine; Hyperglycemia ≥ 5.6 (mmol/L) or glucose lowering medication; MetS is defined as having 3 MetS features measured in Doetinchem Cohort
  3. bNon-fasting values